Vimarsana
Biggest News Aggregation in the World

Page 13 - Restricted Use News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Restricted Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Restricted Use Today - Breaking & Trending Today

Our vaccine highly effective on Covid-19 variant prevalent in India, suitable for 12 years and above: Pfizer to Govt | India News - Vimarsana News

Our vaccine highly effective on Covid-19 variant prevalent in India, suitable for 12 years and above: Pfizer to Govt | India News

NEW DELHI: Seeking a fast-track approval for its Covid-19 vaccine, US major Pfizer has told Indian authorities that its jab has shown "high effectiveness" against the SARS-CoV-2 variant prevalent in India and on people of Indian ethnicity or nationality, while it is suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees, sources said on Wednesday. Pfizer, which is ready to offer 5 crore doses to India between July and October this year and has sought certain relaxations including indemnification, has held a series of interactions with the Indian government ...

Our vaccine highly effective on COVID-19 variant prevalent in India, suitable for 12 years and above: Pfizer to Govt - Vimarsana News

Our vaccine highly effective on COVID-19 variant prevalent in India, suitable for 12 years and above: Pfizer to Govt

Pfizer, which is ready to offer 5 crore doses to India between July and October this year and has sought certain relaxations including indemnification, has held a series of interactions with the Indian government authorities recently including one this week, during which it shared the most recent data points regarding efficacy trials and approvals for its vaccine in various countries and by the WHO.

Our vaccine highly effective on COVID-19 variant prevalent in India, suitable for 12 years and above- The New Indian Express - Vimarsana News

Our vaccine highly effective on COVID-19 variant prevalent in India, suitable for 12 years and above- The New Indian Express

Our vaccine highly effective on COVID-19 variant prevalent in India, suitable for 12 years and above: Pfizer to government The data shared with Indian authorities include real-world evidence of BNT162b2 vaccine effectiveness and safety from national immunization programmes. Share Via Email   |  A+A A- By PTI NEW DELHI: Seeking a fast-track approval for its COVID-19 vaccine, US major Pfizer has told Indian authorities that its jab has shown "high effectiveness" against the SARS-CoV-2 variant prevalent in India and on people of Indian ethnicity or nationality, while it is suitable for e...

Pfizer seeks fast-track approval, tells govt its vaccine is 'highly effective' on variant prevalent in India - Vimarsana News

Pfizer seeks fast-track approval, tells govt its vaccine is 'highly effective' on variant prevalent in India

Pfizer seeks fast-track approval, tells govt its vaccine is 'highly effective' on variant prevalent in India Pfizer has sought a fast-track approval for its Covid-19 vaccine, stating that the vaccine is "highly effective" against the variant prevalent in India. advertisement UPDATED: May 27, 2021 07:41 IST Pfizer said its vaccine is suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees. (Photo: Reuters) US pharma giant Pfizer on Wednesday told the central government that its Covid-19 vaccine is "highly effective" against the Covid-19 variant that is prevale...

Our vaccine highly effective on Covid-19 variant prevalent in India: Pfizer - Vimarsana News

Our vaccine highly effective on Covid-19 variant prevalent in India: Pfizer

Seeking a fast-track approval for its COVID-19 vaccine, US major Pfizer has told Indian authorities that its jab has shown "high effectiveness" against the SARS-CoV-2 variant prevalent in India and on people of Indian ethnicity or nationality, while it is suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees, sources said on Wednesday. Pfizer, which is ready to offer 5 crore doses to India between July and October this year and has sought certain relaxations including indemnification, has held a series of interactions with the Indian government authoritie...